2025 Q2 Colombia Pharmaceutical products (HS3004) Export Snapshot: Volatile Trends

Q2 Trend: Colombia Pharmaceutical products Export

Pharmaceutical products, classified under HS Code 3004 (Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses or in forms or packings for retail sale.), saw volatile unit prices in Q2, dropping 32% in May before rebounding 32% in June. Export value peaked at $34.40M in May, up 21% month-on-month, while volume surged 78% to 6.39M kg before retreating 27% the following month. The data reflects sharp swings in trade activity without clear external catalysts.

Table: Colombia Pharmaceutical Products Export Trend (Source: yTrade)

Get Colombia Pharmaceutical Products Historical Export Data

Geographic Concentration & Market Logic

Colombia's pharmaceutical exports are dominated by SOUTH GEORGIA AND THE SOUTH SANDWICH ISLANDS, accounting for 14.65% of export value but just 13.68% of weight, signaling a premium market demanding high-value finished products. The stark value-volume gap in Peru (21.19% weight share vs. 9.29% value) reveals it as a bulk hub for raw materials, while Chile’s 31.53% weight share (6.97% value) further confirms this cost-driven supply chain logic. The presence of small island markets (e.g., Northern Mariana Islands) with disproportionate value shares suggests niche, high-margin opportunities. Strategic takeaway: Colombia’s export structure prioritizes premium markets for finished goods and bulk routes for raw materials, optimizing for value capture over volume efficiency.

Table: Colombia Pharmaceutical Products (HS Code 3004) Top Destination Countries (Source: yTrade)

Get Complete Colombia Pharmaceutical Products Destination Countries Profile

Colombia HS Code 3004 Breakdown & Value Logic

yTrade data reveals HS Code 3004902900 (mixed medicaments for retail) dominates Colombia's Q2 2025 exports, capturing 60% of value and 93% of quantity—a clear volume-driven play. The remaining sub-codes (e.g., antibiotic or vitamin-based medicaments) collectively contribute marginal shares, suggesting Colombia HS Code 3004 Export thrives on standardized, high-volume production rather than premium-priced niches. This confirms a market anchored in low-cost bulk trade, with scalability outweighing unit-price differentiation.

Table: Colombia (HS Code 3004) Breakdown Details (Source: yTrade)

Check Detailed HS Code 3004 Breakdown

Colombia Pharmaceutical Products Buyers List

Table: Colombia Pharmaceutical Products (HS Code 3004) Top Buyers List (Source: yTrade)

Check Full Pharmaceutical products Buyers list

Frequently Asked Questions

How did Colombia Pharmaceutical products Export perform in Q2?

Exports surged 20.69% month-on-month in May to $34.40M, then dipped 3.19% in June to $33.30M, with unit prices volatile (-32.23% in May, +32.29% in June).

What are the top Export partners for Colombia Pharmaceutical products?

South Georgia and the South Sandwich Islands ($13.94M), Peru ($8.84M), and Ecuador ($7.92M) were the top destinations.

Who are the major Pharmaceutical products Buyers?

Laboratorios Siegfried S.A ($3.88M) and Tecnoquimicas de El Salvador S A de C V ($3.87M) led buyer activity.

What is the specific HS Code for this trade?

The data covers HS Code 3004, with significant activity in medicaments for therapeutic uses (HS 300490****, $57.87M).

Detailed Monthly Report

Colombia HS3004 Export Snapshot 2025 APR

Colombia HS3004 Export Snapshot 2025 MAY

Colombia HS3004 Export Snapshot 2025 JUN